Makoto Sano

Oyaguchi, 1738610, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

Blocking L-carnitine synthesis by meldonium prolongs the survival in mice with pancreatic cancer.

Blocking L-carnitine synthesis by meldonium prolongs the survival in mice with pancreatic cancer.

Journal: iScience

Published: October 03, 2025

High-Dose Tramadol Enhances the Proliferative and Invasive Potential of Pancreatic Ductal Adenocarcinoma in Mice Through Microenvironmental Alteration.

High-Dose Tramadol Enhances the Proliferative and Invasive Potential of Pancreatic Ductal Adenocarcinoma in Mice Through Microenvironmental Alteration.

Journal: Pain research & management

Published: August 02, 2025

Effects of cardiopulmonary bypass on in vitro proliferation of human pancreatic cancer cells and plasma growth factor levels.

Effects of cardiopulmonary bypass on in vitro proliferation of human pancreatic cancer cells and plasma growth factor levels.

Journal: Journal of cardiothoracic surgery

Published: June 23, 2025

Duloxetine improves hyperosmia in mice with pancreatic cancer by increasing dopamine levels in the olfactory bulb.

Duloxetine improves hyperosmia in mice with pancreatic cancer by increasing dopamine levels in the olfactory bulb.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: January 18, 2025

Blockade of CC chemokine receptor 2 suppresses pancreatic cancer progression through the interaction with macrophages in the tumor microenvironment.

Blockade of CC chemokine receptor 2 suppresses pancreatic cancer progression through the interaction with macrophages in the tumor microenvironment.

Journal: Scientific reports

Published: December 21, 2024

Pregabalin enhances the proliferative potential of pancreatic cancer in vitro but not in mice with pancreatic cancer.

Pregabalin enhances the proliferative potential of pancreatic cancer in vitro but not in mice with pancreatic cancer.

Journal: BMC pharmacology & toxicology

Published: July 18, 2024

The role of DPYD and the effects of DPYD suppressor luteolin combined with 5-FU in pancreatic cancer.

The role of DPYD and the effects of DPYD suppressor luteolin combined with 5-FU in pancreatic cancer.

Journal: Cancer medicine

Published: April 17, 2024

Effects of tramadol via a µ-opioid receptor on pancreatic ductal adenocarcinoma in vitro and in vivo.

Effects of tramadol via a µ-opioid receptor on pancreatic ductal adenocarcinoma in vitro and in vivo.

Journal: Regional anesthesia and pain medicine

Published: March 19, 2023

Mirogabalin improves cancer-associated pain but increases the risk of malignancy in mice with pancreatic cancer.

Mirogabalin improves cancer-associated pain but increases the risk of malignancy in mice with pancreatic cancer.

Journal: Pain

Published: September 01, 2022

Overcoming resistance of stroma-rich pancreatic cancer with focal adhesion kinase inhibitor combined with G47Δ and immune checkpoint inhibitors.

Overcoming resistance of stroma-rich pancreatic cancer with focal adhesion kinase inhibitor combined with G47Δ and immune checkpoint inhibitors.

Journal: Molecular therapy oncolytics

Published: May 27, 2022

Delivery of aPD-L1 antibody to i.p. tumors via direct penetration by i.p. route: Beyond EPR effect.

Delivery of aPD-L1 antibody to i.p. tumors via direct penetration by i.p. route: Beyond EPR effect.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: May 10, 2022

Midazolam exhibits antitumour and anti-inflammatory effects in a mouse model of pancreatic ductal adenocarcinoma.

Midazolam exhibits antitumour and anti-inflammatory effects in a mouse model of pancreatic ductal adenocarcinoma.

Journal: British journal of anaesthesia

Published: August 27, 2021

Showing 1-12 of 26

Last Updated: 09/26/2026